ProterixBio, Inc. will be attending Biotech Showcase™ 2018, to be held January 8-10th at the Hilton San Francisco Union Square. Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year.
Michael F. Miller, Ph.D., president and chief executive officer of ProterixBio, will speak at the conference. He will be highlighting ProterixBio’s proprietary molecular assessments to improve care and accelerate therapeutics development for patients with chronic respiratory diseases. The company’s first product is focused on COPD (chronic obstructive pulmonary disease) which is a leading cause of death and contributor to health care spending worldwide.